|
| Themes | Extract |
|
| Time, cost, and resources | “In community practice I think that there is not enough time, resources or staff to carry out this.”-Preregistration pharmacist |
| “Believe would be financially not feasible, and also possibly very demanding of my already stretched time”-Qualified Pharmacist (>10 years) |
| “…Only limitation might be limited resources to do the tests-remuneration?”-Qualified Pharmacist (≤10 years) |
| “In principle I think it may be the way forward and improve safer, more rationale prescribing however funding may be an issue”-Qualified Pharmacist (>10 years) |
| “Could save time and resources by screening for the most effective/least side effect profile for a given individual better for the patient and NHS”-Undergraduate |
| “I think we should be making use of advancements in technology to optimise patient’s regimens. Only limitation might be limited resources to do the tests-remuneration?”-Qualified Pharmacist (>10 years) |
|
| Responsibility for testing | “… decision should lie with prescriber”-Qualified Pharmacist (>10 years) |
| “Pharmacists with the correct amount of clinical training are the drug experts and on that basis are more qualified to advise on these issues than other members of the primary care team, including GPs.”-Qualified Pharmacist (>10 years) |
| “The genetic test and appropriateness should be at prescribing level-more so now so much dispensing is remote internet pharmacy etc”-Qualified Pharmacist (>10 years) |
| “Such testing should be done at the point of prescribing and the result communicated to the pharmacist. Performing such a test would, in my opinion, constitute part of the prescribing process, not the dispensing/clinical check process. The result should definitely be accessible to the dispensing pharmacy to allow them to confirm that the prescription is clinically appropriate for the patient.”-Qualified Pharmacist (≤10 years) |
| “Community setting is perfectly positioned to offer this service as pharmacists have the most time to spend with patients compared to other clinicians”-Qualified Pharmacist (>10 years) |
|
| Data integrity/secondary findings | “…I would be concerned on the repercussions of this technology as ultimately this data could harm patient confidentiality.”-Undergraduate |
| “I would [use POC PGx testing] if it was supported by a decent evidence base and the test was cost effective. My one major concern is that we will introduce screening for genetic mutations and expose people to the harms that you get with every screening programme. I dont think this has been considered widely enough as people just assume a genetic test means personalised treatment which they always assume is better (I think)”-Qualified Pharmacist (≤10 years) |
|
| Education and guidelines | “After increasing knowledge within this new area and specific training I can see an opportunity for community pharmacy to provide this service. I do see a place in the future for this in the UK”-Qualified Pharmacist (>10 years) |
| “If I was given more support and increased my knowledge of the subject I feel it would be appropriate to do in a healthcare setting as a pharmacist although I do feel more legislation is needed before I can do so.”-Preregistration Pharmacist |
| “Don’t know enough about it to make decision based on results”-Qualified Pharmacist (≤10 years) |
|
